Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/17/20248:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALLGAllego NV
06/17/20248:36AMPR Newswire (US)Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
06/17/20248:36AMPR Newswire (Canada)Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
06/17/20248:36AMPR Newswire (US)CH4 Global and CirPro Australia announce successful processing of first cattle to be fed Methane Tamer™ at commercial scale
06/17/20248:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTEAerovate Therapeutics Inc
06/17/20248:35AMBusiness WireBeyond, Inc. Announces Structural Leadership ChangesNYSE:BYONBeyond Inc
06/17/20248:35AMGlobeNewswire Inc.Triumph Financial and C.H. Robinson Announce Strategic RelationshipNASDAQ:TFINTriumph Financial Inc
06/17/20248:35AMGlobeNewswire Inc.Triumph Financial and C.H. Robinson Announce Strategic RelationshipNASDAQ:CHRWCH Robinson Worldwide Inc
06/17/20248:35AMPR Newswire (US)Production Equipment from Major Stretch-Film Manufacturer Goes to Auction June 26
06/17/20248:35AMPR Newswire (US)Maxeon to Showcase Latest Solar Energy Innovations and New Panel Technologies at Intersolar Europe 2024NASDAQ:MAXNMaxeon Solar Technologies Ltd
06/17/20248:35AMPR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - CBST
06/17/20248:33AMAlliance NewsAlliance NewsCizzle says CIZ1B biomarker test picked for "major" US cancer studyLSE:CIZCizzle Biotechnology Holdings Plc
06/17/20248:33AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:SCCGSachem Capital Corp
06/17/20248:33AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:OHCSOptimus Healthcare Services Inc (PK)
06/17/20248:33AMPR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - CBST
06/17/20248:33AMPR Newswire (US)Prime Jet Celebrates 13 Years of Excellence in Private Aviation
06/17/20248:33AMPR Newswire (US)Onecent Technology: Pioneering Social Connections in Gaming
06/17/20248:32AMGlobeNewswire Inc.Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in CamelinaNASDAQ:YTENYield10 Bioscience Inc
06/17/20248:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
06/17/20248:32AMGlobeNewswire Inc.Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial HypertensionNASDAQ:AVTEAerovate Therapeutics Inc
06/17/20248:31AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:LNGCheniere Energy Inc
06/17/20248:31AMBusiness WireRealPage Showcases AI-Enabled Innovations at Apartmentalize 2024
06/17/20248:31AMPR Newswire (US)Human8 Releases Fresh Research on How Consumers are Embracing Life and Experiences Amid Chaos
06/17/20248:31AMPR Newswire (US)365 Connect to Showcase AI-Powered Marketing and Leasing Platform at Apartmentalize Conference in Philadelphia
06/17/20248:31AMPR Newswire (US)Hi-Tech Pharmaceuticals Forms Joint Ventures to Keep Up With Demand of Berberine Cyclosome® - A Revolutionary Breakthrough in Blood Sugar Metabolism Support and Weight Management
06/17/20248:30AMEdgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NYSE:XYFX Financial
06/17/20248:30AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GANXGain Therapeutics Inc
06/17/20248:30AMGlobeNewswire Inc.P10 Announces Results of its Annual Meeting of StockholdersNYSE:PXP10 Inc
06/17/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATRAAtara Biotherapeutics Inc
06/17/20248:30AMGlobeNewswire Inc.Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T TherapyNASDAQ:MBIOMustang Bio Inc

Your Recent History

Delayed Upgrade Clock